Navigation Links
Bioenergy Life Science Retains Xsto Solutions to Market D-Ribose
Date:12/11/2008

MINNEAPOLIS, Dec. 11 /PRNewswire/ -- Bioenergy Life Science -- The Ribose Company -- has announced that it has retained Xsto Solutions, LLC, to market Bioenergy D-Ribose(TM) in the Eastern U.S. D-Ribose is a naturally-occurring monosaccharide the body uses to stimulate the synthesis of adenosine triphosphate (ATP) -- an essential energy compound.

"Collaborating with Xsto Solutions will enhance our efforts toward expanding D-Ribose into the marketplace," said Kathy Lund, vice president marketing and sales of Bioenergy Life Science, Ribose Ingredient Division. "D-Ribose is already included in over 100 functional foods and beverages. Aligning ourselves with Xsto Solutions means that more companies will incorporate this natural energy booster."

"Bioenergy D-Ribose is perhaps the most important nutritional discovery of the decade," says Dan Murray, Xsto Solutions vice president of business development. "We're very excited about aggressively expanding the exposure of D-Ribose within the supplement, functional foods and sports nutrition industries."

Although ribose is produced by the body naturally to regulate the synthesis of ATP, it cannot be replenished fast enough during certain forms of demanding exercise. When added to foods and dietary supplements, ribose enhances the body's natural process of energy synthesis. It helps reduce the loss of energy during stress and accelerates energy and tissue recovery.

Bioenergy, which recently achieved GRAS (generally recognized as safe) status for D-Ribose from the U.S. Food and Drug Administration, has amassed a large body of scientific literature regarding uses of ribose for people across all age and health categories. The company has more than 40,000 customers for its proprietary Corvalen(R) products alone, and millions worldwide use Bioenergy D-Ribose in other functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water).

Bioenergy, Inc. (http://www.bioenergy.com) is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-Ribose for health and wellness. In addition to a pharmaceutical subsidiary, Bioenergy has two other companies. Bioenergy Life Science, Inc. manufactures and sells D-Ribose as an ingredient to nutraceutical firms for beverages and foods; as a medical food through doctors and clinics; and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is developing technology related to the enhancement of blood components.

Xsto Solutions, LLC (http://www.xstosolutions.com), was established in 2004 and is headquartered in Morristown, New Jersey. Xsto's core focus is bringing a small number of new science-supported nutritional ingredients to the dietary supplement and functional food market. Xsto personnel have successfully and profitably launched new products, driving sales by acting as US-based sales and marketing partners. Xsto has also partnered with small-to medium-sized dietary supplement manufacturers to increase sales and marketing focus.


'/>"/>
SOURCE Bioenergy Life Science
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
2. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
3. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
5. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
6. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. SAMHSA Announces First Science and Service Award Winners
10. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
11. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... hair transplantation therapy, is proud to announce a new informational post on robotic ... procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) can ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced ... February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of ... use behavioral health analytics to improve Medicaid population health management. , ODH will also ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... on tooth replacement options at his office, Antoine Dental Center. Currently, patients can ... $18,499. Some restrictions may apply, but patients can learn more about these offers ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , February 27, 2017 A recent research ... medical marijuana market alone is expected to reach a value of ... along with 28 states have legalized marijuana for medical ... Florida , North Dakota , ... were approved to use the drug in medical applications such as ...
(Date:2/27/2017)... 2017 The Dutch secure mobile ... use at the security level RESTRICTED. The solution thus meets ... for the communication of classified information. ... Sectra and Samsung have a ... smartphone solution. Sectra Tiger/R is developed by Sectra under guidance ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of the ... 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow at ... $2.9 billion by 2025. This industry report analyzes the ... well as regional levels presented in the research scope. The study provides ...
Breaking Medicine Technology: